BKHAR
Black Hawk Acquisition Corp
Key Financials
Operating Income
$-915510
↓ 58.9%
Net Income
$1.3M
↓ 30.6%
Total Assets
$23.9M
↓ 66.9%
Total Liabilities
$3.9M
↑ 56.8%
Shareholders' Equity
$-3846443.00
↓ 77.1%
Cash & Equivalents
$0.00
NaN%
Operating Cash Flow
$-650321.00
↓ 17.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 10/13/2026 | View on SEC |
| SCHEDULE 13G/A | 10/7/2026 | View on SEC |
| 10-Q | 10/6/2026 | View on SEC |
| 425 | 9/25/2026 | View on SEC |
| 8-K | 9/24/2026 | View on SEC |
| 8-K | 9/22/2026 | View on SEC |
| 424B4 | 9/22/2026 | View on SEC |
| EFFECT | 9/17/2026 | View on SEC |
| S-4/A | 9/4/2026 | View on SEC |
| 8-K | 8/26/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BKHAR |
| Company Name | Black Hawk Acquisition Corp |
| CIK | 2000775 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1130 |
| Phone | 203-520-7122 |